MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated

Lung cancer is the leading cause of cancer deaths, and effective treatments are urgently needed. Loss-of-function mutations in the DNA damage response kinase ATM are common in lung adenocarcinoma but directly targeting these with drugs remains challenging. Here we report that ATM loss-of-function is...

Descripción completa

Detalles Bibliográficos
Autores principales: Smida, Michal, Fece de la Cruz, Ferran, Kerzendorfer, Claudia, Uras, Iris Z., Mair, Barbara, Mazouzi, Abdelghani, Suchankova, Tereza, Konopka, Tomasz, Katz, Amanda M., Paz, Keren, Nagy-Bojarszky, Katalin, Muellner, Markus K., Bago-Horvath, Zsuzsanna, Haura, Eric B., Loizou, Joanna I., Nijman, Sebastian M. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5150652/
https://www.ncbi.nlm.nih.gov/pubmed/27922010
http://dx.doi.org/10.1038/ncomms13701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5150652/
https://www.ncbi.nlm.nih.gov/pubmed/27922010
http://dx.doi.org/10.1038/ncomms13701

Ejemplares similares